These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 28702897)
1. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient. Njoroge SW; Burgess KR; Cobleigh MA; Alnajar HH; Gattuso P; Usha L Breast Cancer Res Treat; 2017 Nov; 166(1):315-319. PubMed ID: 28702897 [TBL] [Abstract][Full Text] [Related]
2. Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing? Infante M; Arranz-Ledo M; Lastra E; Abella LE; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232793 [TBL] [Abstract][Full Text] [Related]
3. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394 [TBL] [Abstract][Full Text] [Related]
6. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215 [TBL] [Abstract][Full Text] [Related]
8. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests. Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829 [TBL] [Abstract][Full Text] [Related]
9. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
10. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry. Casey MJ; Bewtra C; Lynch HT; Snyder C; Stacy M; Watson P Fam Cancer; 2013 Dec; 12(4):719-40. PubMed ID: 23666231 [TBL] [Abstract][Full Text] [Related]
12. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. Crawford B; Adams SB; Sittler T; van den Akker J; Chan S; Leitner O; Ryan L; Gil E; van 't Veer L Breast Cancer Res Treat; 2017 Jun; 163(2):383-390. PubMed ID: 28281021 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
14. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel. Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748 [TBL] [Abstract][Full Text] [Related]
15. Genetic testing by cancer site: stomach. Chun N; Ford JM Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738 [TBL] [Abstract][Full Text] [Related]
16. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Casey MJ; Bewtra C Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851 [TBL] [Abstract][Full Text] [Related]
17. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis. Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R Oncology; 2015; 88(4):226-33. PubMed ID: 25503195 [TBL] [Abstract][Full Text] [Related]